Literature DB >> 24273861

Immunomodulatory activities of alpha-mangostin on peripheral blood mononuclear cells.

Pimolkan Kasemwattanaroj1, Primchanien Moongkarndi, Kovit Pattanapanyasat, Supachoke Mangmool, Ekkarat Rodpai, Jutima Samer, Julaporn Konlata, Kasama Sukapirom.   

Abstract

Mangosteen (Garcinia mangostana L.) a tropical fruit, has been used in traditional medicine. A frequently used part of mangosteen is the pericarp, containing a high content of xanthones. alpha-Mangostin, one of the major xanthone derivatives, exhibits a variety of actions, including antimicrobial, antioxidant, cytotoxic and antitumor; however, its function on the immune system is still equivocal. This study aimed to examine the immunomodulatory activities of alpha-mangostin on lymphocyte lineage and cytokine production in human peripheral blood mononuclear cells (PBMCs). The cytotoxic activity of alpha-mangostin was measured by MTT assay. The concentration of alpha-mangostin at 5.55 microg/mL resulted in a 50% survival of PBMCs, which was as potent a cytotoxic activity as that of paclitaxel. After 24 h of PBMCs culture, the percentages of T cells (CD3+), B cells (CD19+) and NK cells (CD3-CD16+CD56+) were not significantly changed by treatment with 1, 2 and 4 microg/mL of alpha-mangostin compared with untreated-PBMCs; in addition, the percentages of these lymphocytes treated with the combination of alpha-mangostin (1, 2 and 4 microg/mL) and the mitogen concanavalin A (ConA) was not significantly different from that of ConA-treated PBMCs. For cytokine secretion, alpha-mangostin (1, 2 and 4 microg/mL) did not significantly induce either proinflammatory cytokines (i.e., TNF-alpha and IL-1beta) or cytokine of adaptive immunity (i.e., IL-2). The combination of alpha-mangostin (1, 2 and 4 microg/mL) and ConA did not significantly alter the relative difference of TNF-alpha and IL-1beta compared with ConA-treated PBMCs; however, these combinations could significantly decrease the relative difference of IL-2 compared with ConA-treated PBMCs. These data indicated that alpha-mangostin was able to inhibit IL-2 release without interfering with human immune cells; therefore, further studies are necessary to investigate its effect on IL-2 production.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24273861

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN: 1555-9475            Impact factor:   0.986


  5 in total

1.  Activation of cholinergic anti-inflammatory pathway involved in therapeutic actions of α-mangostin on lipopolysaccharide-induced acute lung injury in rats.

Authors:  Zhe Yang; Qin Yin; Opeyemi Joshua Olatunji; Yan Li; Shu Pan; Dan-Dan Wang; Jian Zuo
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

2.  Inhibitory effects of α-Mangostin on T cell cytokine secretion via ORAI1 calcium channel and K+ channels inhibition.

Authors:  Hyun Jong Kim; Seorin Park; Hui Young Shin; Yu Ran Nam; Phan Thi Lam Hong; Young-Won Chin; Joo Hyun Nam; Woo Kyung Kim
Journal:  PeerJ       Date:  2021-03-03       Impact factor: 2.984

Review 3.  The Potential of α-Mangostin from Garcinia mangostana as an Effective Antimicrobial Agent-A Systematic Review and Meta-Analysis.

Authors:  Omer Sheriff Sultan; Haresh Kumar Kantilal; Suan Phaik Khoo; Amalraj Fabian Davamani; Sumaiya Zabin Eusufzai; Farah Rashid; Nafij Bin Jamayet; Jue Ann Soh; Yen Yee Tan; Mohammad Khursheed Alam
Journal:  Antibiotics (Basel)       Date:  2022-05-26

4.  Contribution of reactive oxygen species to the anticancer activity of aminoalkanol derivatives of xanthone.

Authors:  Daniel Sypniewski; Natalia Szkaradek; Tomasz Loch; Anna M Waszkielewicz; Agnieszka Gunia-Krzyżak; Daria Matczyńska; Dagna Sołtysik; Henryk Marona; Ilona Bednarek
Journal:  Invest New Drugs       Date:  2017-11-08       Impact factor: 3.850

5.  Studies on Haloperidol and Adjunctive α-Mangostin or Raw Garcinia mangostana Linn Pericarp on Bio-Behavioral Markers in an Immune-Inflammatory Model of Schizophrenia in Male Rats.

Authors:  Jana Lotter; Marisa Möller; Olivia Dean; Michael Berk; Brian H Harvey
Journal:  Front Psychiatry       Date:  2020-03-31       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.